The Dividend Yield as of September 2024 (TTM) for NeuBase Therapeutics, Inc. (NBSE) is 0%

According to NeuBase Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

NeuBase Therapeutics, Inc. (NBSE) Historical Dividend Yield (quarterly & annually)

How has NBSE Dividend Yield performed in the past?

The mean historical Dividend Yield of NeuBase Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NBSE's Dividend Yield was at its highest in in the December 2013 quarter at 0%. The Dividend Yield was at its lowest in in the December 2013 quarter at 0%.

NeuBase Therapeutics, Inc. (NBSE) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of NeuBase Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuBase Therapeutics, Inc. (NBSE) Average Dividend Yield

How has NBSE Dividend Yield performed in the past?

The current Dividend Yield of NeuBase Therapeutics, Inc. (NBSE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeuBase Therapeutics, Inc. (NBSE) Dividend Yield vs. Peers

How is NBSE’s Dividend Yield compared to its peers?

NeuBase Therapeutics, Inc.’s Dividend Yield is less than Immix Biopharma, Inc. (0%), less than CNS Pharmaceuticals, Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%), less than Navidea Biopharmaceuticals, Inc. (0%), less than Sonnet BioTherapeutics Holdings, Inc. (0%), less than Kiromic BioPharma, Inc. (0%), less than ZyVersa Therapeutics, Inc. (0%), less than YS Biopharma Co., Ltd. (0%), less than BiomX Inc. (0%), less than Landos Biopharma, Inc. (0%), less than Apexigen, Inc. (0%), less than Angion Biomedica Corp. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than NewAmsterdam Pharma Company N.V. (0%), less than Inventiva S.A. (0%), less than Cullinan Oncology, Inc. (0%), less than Compass Therapeutics, Inc. (0%), less than null (0%),

Build a custom stock screener for NeuBase Therapeutics, Inc. (NBSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuBase Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuBase Therapeutics, Inc. (NBSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuBase Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.